CYTOXAN (LYOPHILIZED) Drug Patent Profile
When do Cytoxan (lyophilized) patents expire, and when can generic versions of Cytoxan (lyophilized) launch?
Cytoxan (lyophilized) is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in CYTOXAN (LYOPHILIZED) is cyclophosphamide. There is one drug master file entry for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cytoxan (lyophilized)
A generic version of CYTOXAN (LYOPHILIZED) was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYTOXAN (LYOPHILIZED)?
- What are the global sales for CYTOXAN (LYOPHILIZED)?
- What is Average Wholesale Price for CYTOXAN (LYOPHILIZED)?
Summary for CYTOXAN (LYOPHILIZED)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,924 |
| DailyMed Link: | CYTOXAN (LYOPHILIZED) at DailyMed |
-patent-expirations.png "CYTOXAN (LYOPHILIZED) drug patent expirations")
Recent Clinical Trials for CYTOXAN (LYOPHILIZED)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| California Institute for Regenerative Medicine (CIRM) | Phase 1 |
| Hideho Okada, MD, PhD | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
US Patents and Regulatory Information for CYTOXAN (LYOPHILIZED)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-004 | Aug 30, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-009 | Dec 10, 1985 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-010 | Sep 24, 1985 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-005 | Aug 30, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-008 | Jan 4, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CYTOXAN (LYOPHILIZED)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-010 | Sep 24, 1985 | 4,537,883 | ⤷ Start Trial |
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-008 | Jan 4, 1984 | 4,537,883 | ⤷ Start Trial |
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-009 | Dec 10, 1985 | 4,537,883 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
